APOL1 risk variants and kidney disease: what we know so far
Autor(a) principal: | |
---|---|
Data de Publicação: | 2018 |
Outros Autores: | , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Jornal Brasileiro de Nefrologia |
Texto Completo: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0101-28002018000400388 |
Resumo: | ABSTRACT There are striking differences in chronic kidney disease between Caucasians and African descendants. It was widely accepted that this occurred due to socioeconomic factors, but recent studies show that apolipoprotein L-1 (APOL1) gene variants are strongly associated with focal segmental glomerulosclerosis, HIV-associated nephropathy, hypertensive nephrosclerosis, and lupus nephritis in the African American population. These variants made their way to South America trough intercontinental slave traffic and conferred an evolutionary advantage to the carries by protecting against forms of trypanosomiasis, but at the expense of an increased risk of kidney disease. The effect of the variants does not seem to be related to their serum concentration, but rather to local action on the podocytes. Risk variants are also important in renal transplantation, since grafts from donors with risk variants present worse survival. |
id |
SBN-1_563ef97ec36c9e0688fe1b4648479757 |
---|---|
oai_identifier_str |
oai:scielo:S0101-28002018000400388 |
network_acronym_str |
SBN-1 |
network_name_str |
Jornal Brasileiro de Nefrologia |
repository_id_str |
|
spelling |
APOL1 risk variants and kidney disease: what we know so farGenetics;Apolipoprotein L1KidneyGlomerulosclerosis, Focal SegmentalAIDS-Associated NephropathyNephrosclerosisRenal Insufficiency, ChronicABSTRACT There are striking differences in chronic kidney disease between Caucasians and African descendants. It was widely accepted that this occurred due to socioeconomic factors, but recent studies show that apolipoprotein L-1 (APOL1) gene variants are strongly associated with focal segmental glomerulosclerosis, HIV-associated nephropathy, hypertensive nephrosclerosis, and lupus nephritis in the African American population. These variants made their way to South America trough intercontinental slave traffic and conferred an evolutionary advantage to the carries by protecting against forms of trypanosomiasis, but at the expense of an increased risk of kidney disease. The effect of the variants does not seem to be related to their serum concentration, but rather to local action on the podocytes. Risk variants are also important in renal transplantation, since grafts from donors with risk variants present worse survival.Sociedade Brasileira de Nefrologia2018-12-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0101-28002018000400388Brazilian Journal of Nephrology v.40 n.4 2018reponame:Jornal Brasileiro de Nefrologiainstname:Sociedade Brasileira de Nefrologia (SBN)instacron:SBN10.1590/2175-8239-jbn-2017-0033info:eu-repo/semantics/openAccessSiemens,Tobias AugustRiella,Miguel CarlosMoraes,Thyago Proença deRiella,Cristian Vidaleng2019-02-05T00:00:00Zoai:scielo:S0101-28002018000400388Revistahttp://www.bjn.org.br/ONGhttps://old.scielo.br/oai/scielo-oai.php||jbn@sbn.org.br2175-82390101-2800opendoar:2019-02-05T00:00Jornal Brasileiro de Nefrologia - Sociedade Brasileira de Nefrologia (SBN)false |
dc.title.none.fl_str_mv |
APOL1 risk variants and kidney disease: what we know so far |
title |
APOL1 risk variants and kidney disease: what we know so far |
spellingShingle |
APOL1 risk variants and kidney disease: what we know so far Siemens,Tobias August Genetics;Apolipoprotein L1 Kidney Glomerulosclerosis, Focal Segmental AIDS-Associated Nephropathy Nephrosclerosis Renal Insufficiency, Chronic |
title_short |
APOL1 risk variants and kidney disease: what we know so far |
title_full |
APOL1 risk variants and kidney disease: what we know so far |
title_fullStr |
APOL1 risk variants and kidney disease: what we know so far |
title_full_unstemmed |
APOL1 risk variants and kidney disease: what we know so far |
title_sort |
APOL1 risk variants and kidney disease: what we know so far |
author |
Siemens,Tobias August |
author_facet |
Siemens,Tobias August Riella,Miguel Carlos Moraes,Thyago Proença de Riella,Cristian Vidal |
author_role |
author |
author2 |
Riella,Miguel Carlos Moraes,Thyago Proença de Riella,Cristian Vidal |
author2_role |
author author author |
dc.contributor.author.fl_str_mv |
Siemens,Tobias August Riella,Miguel Carlos Moraes,Thyago Proença de Riella,Cristian Vidal |
dc.subject.por.fl_str_mv |
Genetics;Apolipoprotein L1 Kidney Glomerulosclerosis, Focal Segmental AIDS-Associated Nephropathy Nephrosclerosis Renal Insufficiency, Chronic |
topic |
Genetics;Apolipoprotein L1 Kidney Glomerulosclerosis, Focal Segmental AIDS-Associated Nephropathy Nephrosclerosis Renal Insufficiency, Chronic |
description |
ABSTRACT There are striking differences in chronic kidney disease between Caucasians and African descendants. It was widely accepted that this occurred due to socioeconomic factors, but recent studies show that apolipoprotein L-1 (APOL1) gene variants are strongly associated with focal segmental glomerulosclerosis, HIV-associated nephropathy, hypertensive nephrosclerosis, and lupus nephritis in the African American population. These variants made their way to South America trough intercontinental slave traffic and conferred an evolutionary advantage to the carries by protecting against forms of trypanosomiasis, but at the expense of an increased risk of kidney disease. The effect of the variants does not seem to be related to their serum concentration, but rather to local action on the podocytes. Risk variants are also important in renal transplantation, since grafts from donors with risk variants present worse survival. |
publishDate |
2018 |
dc.date.none.fl_str_mv |
2018-12-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0101-28002018000400388 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0101-28002018000400388 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
10.1590/2175-8239-jbn-2017-0033 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Sociedade Brasileira de Nefrologia |
publisher.none.fl_str_mv |
Sociedade Brasileira de Nefrologia |
dc.source.none.fl_str_mv |
Brazilian Journal of Nephrology v.40 n.4 2018 reponame:Jornal Brasileiro de Nefrologia instname:Sociedade Brasileira de Nefrologia (SBN) instacron:SBN |
instname_str |
Sociedade Brasileira de Nefrologia (SBN) |
instacron_str |
SBN |
institution |
SBN |
reponame_str |
Jornal Brasileiro de Nefrologia |
collection |
Jornal Brasileiro de Nefrologia |
repository.name.fl_str_mv |
Jornal Brasileiro de Nefrologia - Sociedade Brasileira de Nefrologia (SBN) |
repository.mail.fl_str_mv |
||jbn@sbn.org.br |
_version_ |
1752122065065869312 |